Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation - Summary - MDSpire

Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation

  • By

  • Yasuyuki Miyake

  • Shoichi Iriguchi

  • Ai Kawana-Tachikawa

  • Shuichi Kitayama

  • Eri Imai

  • Kahoru Taya

  • Hiroshi Ishii

  • Tomoyuki Miura

  • Hiromi Sakawaki

  • Tetsuro Matano

  • Shin Kaneko

  • May 27, 2026

  • 0 min

Share

Objective:

To correct the funding statement in the published article regarding the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation due to an error.

Key Findings:
  • The original funding statement contained an error: it listed grant numbers as '15H04655, JP17fk0410305, JP25fk0410059'.
  • The correct funding statement includes an additional grant number: JP25fk0410060.
Interpretation:

The correction ensures accurate attribution of funding sources for the research.

Limitations:
Conclusion:

The article has been updated to reflect the correct funding information, correcting the previous error.

Original Source(s)

Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation

  • by Yasuyuki Miyake, Shoichi Iriguchi, Ai Kawana-Tachikawa, Shuichi Kitayama, Eri Imai, Kahoru Taya, Hiroshi Ishii, Tomoyuki Miura, Hiromi Sakawaki, Tetsuro Matano, Shin Kaneko

  • May 27, 2026

Related Content

Case Report: Novel CXCR2 compound heterozygous variants in an infant with neutropenia

Neutrophil α-defensin-1 is present in human stroke thrombi and induces NETosis in vitro

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation